
CAS: 1675201-83-8

(2S)-1-[[2,6-Dimethoxy-4-[(2-methyl[1,1'-biphenyl]-3-yl)methoxy]phenyl]methyl]-2-piperidinecarboxylic acid
CAS:1675201-83-8
Formula:
C29H33NO5
Purity:
98%
Color and Shape:
Solid
Molecular weight:
475.57601999999974
Ref: IN-DA001XF7
1g | To inquire | ||
5mg | 63.00 € | ||
10mg | 97.00 € | ||
25mg | 164.00 € | ||
50mg | 199.00 € | ||
100mg | 267.00 € | ||
250mg | 602.00 € |
Estimated delivery in United States, on Monday 14 Apr 2025

(S)-1-(2,6-Dimethoxy-4-((2-Methyl-[1,1'-Biphenyl]-3-Yl)Methoxy)Benzyl)Piperidine-2-Carboxylic Acid
CAS:1675201-83-8
Purity:
98%
Molecular weight:
475.58g/mol
Ref: 54-OR1022976
1g | 1,356.00 € | ||
100mg | 338.00 € | ||
250mg | 554.00 € |
Estimated delivery in United States, on Tuesday 15 Apr 2025

Ref: 54-BUP07419
25mg | 506.00 € | ||
50mg | 713.00 € | ||
100mg | 1,022.00 € | ||
500mg | 1,968.00 € |
Estimated delivery in United States, on Tuesday 15 Apr 2025

Ref: 4Z-K-031026
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Monday 21 Apr 2025

BMS-1
CAS:1675201-83-8
BMS-1 is a PD-1/PD-L1 inhibitor and immunomodulator; it targets the CD274 gene product, PD-L1, linked …
Formula:
C29H33NO5
Purity:
99.40% - 99.81%
Color and Shape:
Solid
Molecular weight:
475.58
Ref: TM-T3655
1mg | 52.00 € | ||
2mg | 77.00 € | ||
5mg | 110.00 € | ||
10mg | 177.00 € | ||
25mg | 333.00 € | ||
50mg | 477.00 € | ||
100mg | 697.00 € | ||
500mg | 1,454.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025

PD1-PDL1 inhibitor 1
CAS:1675201-83-8
Inhibits interaction between PD1 and PDL1 immune checkpoint proteins
Formula:
C29H33NO5
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
475.58 g/mol
Ref: 3D-BP158531
5mg | 239.00 € | ||
10mg | 358.00 € | ||
25mg | 598.00 € | ||
50mg | 881.00 € |
Estimated delivery in United States, on Friday 25 Apr 2025